A nurse is preparing to administer ticarcillin/clavulanate 3.1 g by intermittent IV bolus over 30 min. Available is ticarcillin/clavulanate 3.1 g in 50 ml 0.9% sodium chloride (NSS). The nurse should set the IV pump to deliver how many mL/hr? (Round the answer to the nearest whole number. Use a leading zero if it applies. Do not use a trailing zero.) _mL/hr

A) Apples:
Apples are not contraindicated with spironolactone use. There are no known interactions between spironolactone and apples.

B) Fish:
Fish is not contraindicated with spironolactone use. There are no known interactions between spironolactone and fish.

C) Crackers:
Crackers are not contraindicated with spironolactone use. There are no known interactions between spironolactone and crackers.

D) Bananas:
Bananas are high in potassium, and spironolactone is a potassium-sparing diuretic. Ingesting potassium-rich foods such as bananas while taking spironolactone can increase the risk of hyperkalemia. Therefore, the nurse should instruct the client to avoid consuming large amounts of potassium-rich foods like bananas to prevent adverse effects."

A) Loss of protective respiratory mechanisms due to prolonged irritation or damage:
Individuals with COPD often experience a progressive loss of protective respiratory mechanisms over time. Chronic exposure to irritants such as cigarette smoke leads to inflammation, structural changes in the airways, and destruction of lung tissue, impairing the body's ability to clear mucus, trap foreign particles, and maintain normal lung function. This loss of protective mechanisms contributes to the hallmark symptoms of COPD, including airflow limitation, chronic cough, and increased susceptibility to respiratory infections.

B) Localized swelling and inflammation within the lungs:
While inflammation is a hallmark feature of COPD, it typically manifests as widespread inflammation throughout the lungs rather than localized swelling. In COPD, chronic exposure to irritants leads to a systemic inflammatory response that affects the entire respiratory tract, including the bronchi and alveoli. This inflammation contributes to airway obstruction, mucus hypersecretion, and the development of respiratory symptoms.

C) An acute viral infection of the respiratory tract:
While individuals with COPD are at increased risk of respiratory infections, including viral infections such as influenza and respiratory syncytial virus (RSV), COPD itself is a chronic, progressive respiratory condition characterized by persistent airflow limitation. Acute viral infections may exacerbate COPD symptoms and lead to worsening respiratory function, but they are not inherent features of the disease itself.

D) Inflammation and swelling of the sinus membranes over a prolonged period:
Sinus inflammation and swelling, known as sinusitis, are not typically considered primary features of COPD. While individuals with COPD may experience comorbid conditions such as chronic rhinosinusitis, which can contribute to respiratory symptoms and exacerbations, sinus inflammation is not a defining characteristic of the disease.